315 related articles for article (PubMed ID: 6340167)
21. Conversion of the C3 component of complement in mice infected with Trypanosoma cruzi.
Irulegui I; Chaves J; Ferri RG; de Souza ZW; de Souza HB; Castilho EA
Rev Inst Med Trop Sao Paulo; 1980; 22(2):62-8. PubMed ID: 6776614
[No Abstract] [Full Text] [Related]
22. Complement studies in children with treated coeliac disease after gluten challenge.
Bosch C; Becker M; Rotthauwe HW; Opferkuch W
Eur J Pediatr; 1980 Aug; 134(2):145-8. PubMed ID: 6904300
[TBL] [Abstract][Full Text] [Related]
23. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
Loos M; Heinz HP
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():67-74. PubMed ID: 6375257
[TBL] [Abstract][Full Text] [Related]
24. Activation of the first component of complement.
Schumaker VN; Zavodszky P; Poon PH
Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
[No Abstract] [Full Text] [Related]
25. [Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media].
Hoffmeister HM; Fuhrer G; Platten HP; Heller W
Rofo; 1987 Dec; 147(6):673-5. PubMed ID: 2827265
[TBL] [Abstract][Full Text] [Related]
26. [Progress in the knowledge of complement. II. Nephritic factors].
Leibowitch J; Lesavre P
Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
[No Abstract] [Full Text] [Related]
27. [Total hemolytic complement, C3 and C3 convertase levels in cardiac and indeterminate forms of Chagas' disease].
Shikanai-Yasuda MA; Souza ZT; Yasuda PH; Baueb S; Castilho EA; Irulegui I; Vaz CA
Rev Inst Med Trop Sao Paulo; 1984; 26(1):13-8. PubMed ID: 6431589
[No Abstract] [Full Text] [Related]
28. The Croonian Lecture, 1980. The complex proteases of the complement system.
Porter RR
Proc R Soc Lond B Biol Sci; 1980 Nov; 210(1181):477-98. PubMed ID: 6110208
[TBL] [Abstract][Full Text] [Related]
29. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
30. [Progress on complement protein chemistry and the molecular mechanism of activation. Alternative complement pathway].
Kinoshita T
Nihon Rinsho; 1988 Sep; 46(9):1894-8. PubMed ID: 3241383
[No Abstract] [Full Text] [Related]
31. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
[TBL] [Abstract][Full Text] [Related]
32. [Complement subcomponent C1q in rheumatic diseases].
Yonemasu K; Sasaki T
Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
[No Abstract] [Full Text] [Related]
33. The human alternative complement pathway: biology and immunopathology of activation and regulation.
Kazatchkine MD; Nydegger UE
Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
[No Abstract] [Full Text] [Related]
34. Steady state relations between control proteins regulating the formation of the alternative pathway C3 convertase.
Reeve J; Woo PM
Immunology; 1982 Aug; 46(4):859-66. PubMed ID: 6921154
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
Leist-Welsh P; Bjornson AB
J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
[No Abstract] [Full Text] [Related]
36. The biochemistry of complement.
Porter RR; Reid KB
Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
[TBL] [Abstract][Full Text] [Related]
37. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
[TBL] [Abstract][Full Text] [Related]
38. The classical complement pathway: activation and regulation of the first complement component.
Cooper NR
Adv Immunol; 1985; 37():151-216. PubMed ID: 3890478
[No Abstract] [Full Text] [Related]
39. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary angioedema: description of a sibship and review].
Matter L; Schopfer K; Voegelin HP; Fueter R
Schweiz Med Wochenschr; 1981 Aug; 111(34):1238-45. PubMed ID: 6974398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
